Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels
Although CA 19-9 is a commonly used tumor marker in the management of PBMs, the literature describing outcomes in patients with PBMs who have undetectable or low (hereinafter “low”) CA 19-9 levels remains scarce. In this study, we sought to compare clinical features and outcomes in patients with PBM...
Main Authors: | Jade Law, Harry Trieu, Guneet Kaleka, Joanna Turkiewicz, Samantha Palmer, Jennifer M. Lee, Kathryn T. Chen, James H. Tabibian |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/6/1723 |
Similar Items
-
A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease
by: Mireia Mato Prado, et al.
Published: (2023-12-01) -
Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study
by: Naohiro Kato, et al.
Published: (2023-05-01) -
Pancreaticobiliary Anomalies is the Leading Cause of Childhood Recurrent Pancreatitis
by: Wei-Ju Su, et al.
Published: (2007-01-01) -
Differentiating benign from malignant pancreatic cysts on computed tomography
by: Rajesh Kumar Yadav, et al.
Published: (2020-01-01) -
Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology
by: Alin Mihai Vasilescu, et al.
Published: (2021-11-01)